Each year, oncology professionals around the globe convene for The European Society for Medical Oncology Congress. MD Anderson's experts present the latest advances in cancer care and lead the discussion of its application in the clinic to benefit patients. From promising discoveries in Phase I clinical trials to expanding and improving immunotherapies, our research is saving lives and preserving patients' quality of life.
Below is a snapshot of the work our experts are presenting virtually at The European Society for Medical Oncology Virtual Congress 2020 as well as more on our pacesetting patient care.
BRAF inhibitors and other targeted therapies, as well as a combination of chemotherapy and immunotherapy, are among the new treatments being tested through Phase I clinical trials. Learn about results shared by MD Anderson experts at ESMO Virtual Congress 2020.
Magnetic resonance spectroscopy (MRS) offers potential advantages over the PET scan in providing information about a tumor's metabolic activity. But new research led by MD Anderson shows traditional interpretation of signals from that technique are incorrect.
A first-of-its-kind immunoprevention clinical trial is testing whether an immunotherapy drug can prevent lung cancer in people at high risk for developing the disease. The drug helps the immune system track down and kill pre-cancer cells that may develop into lung cancer.
Moon Shots Program
MD Anderson's Moon Shots® Program aims to rapidly and dramatically improve the disease's survival rates and reduce suffering through early detection, research and new treatments.Learn more about the Moon Shots Program
MD Anderson News
Conferences and Educational Events
View a list of professional, CME-accredited conferences and educational events.